Also from this source

You just read:

GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease

News provided by

Amicus Therapeutics

Oct 29, 2010, 06:50 ET